Invitation to Participate in the Epsilon and qordata AI's Role in Life Sciences Compliance Survey

WASHINGTON, DC USA -- HEALTHCARE UPDATE NEWS SERVICE™ -- JUNE 26, 2026: The Human Genome Project took 13 years to complete; AI capabilities now seem to advance every 13 weeks. Artificial Intelligence is reshaping business processes in a matter of months. AI-enabled capabilities are rapidly becoming part of our daily lives and transforming how organizations operate, make decisions, and manage risk.

But what about AI's role in Life Sciences Compliance?

Many organizations are exploring, piloting, or implementing AI across compliance monitoring, risk assessment, investigations, transparency reporting, auditing, government pricing, and other compliance activities. Yet there is limited benchmarking data available regarding how our peers are using AI, where they are realizing value, and what challenges are limiting broader adoption.

To better understand the current state of AI in Life Sciences Compliance, Epsilon and qordata are sponsoring an industry benchmarking survey focused on:

  • Current AI use cases within compliance programs
  • AI-enabled compliance monitoring and surveillance
  • AI-driven compliance risk assessment and risk prioritization
  • Governance, controls, and organizational readiness
  • Barriers to adoption and scaling
  • Future investment priorities
The survey should take approximately 10-15 minutes to complete.



Survey results will be analyzed in aggregate and shared with the Life Sciences Compliance community at the 27th Annual Pharmaceutical and Medical Device Ethics & Compliance Congress October 13-16, 2026. Our goal is to provide meaningful industry benchmarks that help compliance professionals understand where the industry is today, where value is being achieved, and what factors are influencing broader adoption of AI.

Your participation will help create a valuable resource for compliance leaders across the pharmaceutical, biotechnology, and medical device industries.

Thank you in advance for your time and support.

Saul B. Helman MD, MBA | President
Epsilon Life Sciences
+1.317.294.1228
shelman@epsilonlifesciences.com
Mike O'Connor | CEO
qordata Inc.
+1 (203) 470-4542
mike.oconnor@qordata.com

FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS:

For changes or additions, please email your request to: listmgr@HealthCareUpdateNewsService.com.

For removal of your e-mail address, please click the "SafeUnsubscribe" link located in the footer of this message below to automatically remove your address from the list.